Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.
Veronique BajzikHannah A DeBergNahir GarabatosBlake J RustKimberly K ObrienQuynh-Anh NguyenColin O'RourkeAlex SmithAlex H WalkerCharlie QuinnVivian H GersukMary FarringtonDavid JeongBrian P VickeryDaniel C AdelmanErik R WambrePublished in: Allergy (2022)
Oral desensitization therapy with AR101 leads to decreased basophil sensitivity to peanut and reshapes peanut-reactive T effector cell responses supporting its potential as an immunomodulatory therapy.